[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE60316547D1 - Doping bei der walk-through-mutagenese - Google Patents

Doping bei der walk-through-mutagenese

Info

Publication number
DE60316547D1
DE60316547D1 DE60316547T DE60316547T DE60316547D1 DE 60316547 D1 DE60316547 D1 DE 60316547D1 DE 60316547 T DE60316547 T DE 60316547T DE 60316547 T DE60316547 T DE 60316547T DE 60316547 D1 DE60316547 D1 DE 60316547D1
Authority
DE
Germany
Prior art keywords
prototype
predetermined
synthesis
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60316547T
Other languages
English (en)
Other versions
DE60316547T2 (de
Inventor
Roberto Crea
Guido Cappuccilli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioren LLC
Original Assignee
Bioren LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioren LLC filed Critical Bioren LLC
Application granted granted Critical
Publication of DE60316547D1 publication Critical patent/DE60316547D1/de
Publication of DE60316547T2 publication Critical patent/DE60316547T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1089Design, preparation, screening or analysis of libraries using computer algorithms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102Mutagenizing nucleic acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
DE60316547T 2002-04-17 2003-04-16 Doping bei der walk-through-mutagenese Expired - Lifetime DE60316547T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US37368602P 2002-04-17 2002-04-17
US373686P 2002-04-17
PCT/US2003/011935 WO2003089671A1 (en) 2002-04-17 2003-04-16 'doping' in walk-through mutagenesis

Publications (2)

Publication Number Publication Date
DE60316547D1 true DE60316547D1 (de) 2007-11-08
DE60316547T2 DE60316547T2 (de) 2008-07-03

Family

ID=29251060

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60316547T Expired - Lifetime DE60316547T2 (de) 2002-04-17 2003-04-16 Doping bei der walk-through-mutagenese

Country Status (12)

Country Link
US (1) US20040033569A1 (de)
EP (1) EP1495142B1 (de)
JP (1) JP4433798B2 (de)
CN (1) CN1653193A (de)
AT (1) ATE374255T1 (de)
AU (1) AU2003228568A1 (de)
CA (1) CA2482769C (de)
DE (1) DE60316547T2 (de)
ES (1) ES2295584T3 (de)
MX (1) MXPA04010222A (de)
NZ (1) NZ535928A (de)
WO (1) WO2003089671A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1769003A1 (de) * 2004-07-06 2007-04-04 Bioren, Inc. Hochaffine anti-tnf-alpha-antikörper und verfahren
CA2572961C (en) 2004-07-06 2016-08-16 Bioren, Inc. Universal antibody libraries
ATE528396T1 (de) 2004-07-06 2011-10-15 Bioren Inc Look-through-mutagenese zur entwicklung veränderter polypeptide mit verbesserten eigenschaften
WO2009023184A2 (en) * 2007-08-10 2009-02-19 Protelix, Inc. Universal fibronectin type iii binding-domain libraries
US8680019B2 (en) 2007-08-10 2014-03-25 Protelica, Inc. Universal fibronectin Type III binding-domain libraries
US8470966B2 (en) 2007-08-10 2013-06-25 Protelica, Inc. Universal fibronectin type III binding-domain libraries

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5215889A (en) * 1988-11-18 1993-06-01 The Regents Of The University Of California Catalytic and reactive polypeptides and methods for their preparation and use
ATE126535T1 (de) * 1990-04-05 1995-09-15 Roberto Crea ''walk-through''-mutagenese.
JP3764476B2 (ja) * 1992-06-18 2006-04-05 クリージエン・インコーポレーテツド 組合せポリペプチド抗原
WO1997030150A2 (en) * 1996-02-15 1997-08-21 Pangenetics B.V. Molecules for the induction of immunological tolerance
WO2001048485A2 (en) * 1999-12-27 2001-07-05 Crucell Holland B.V. Selecting library members capable of binding to epitopes

Also Published As

Publication number Publication date
CA2482769A1 (en) 2003-10-30
JP2005523026A (ja) 2005-08-04
ES2295584T3 (es) 2008-04-16
EP1495142B1 (de) 2007-09-26
CA2482769C (en) 2013-10-08
CN1653193A (zh) 2005-08-10
DE60316547T2 (de) 2008-07-03
WO2003089671A1 (en) 2003-10-30
NZ535928A (en) 2006-09-29
AU2003228568A1 (en) 2003-11-03
US20040033569A1 (en) 2004-02-19
EP1495142A1 (de) 2005-01-12
MXPA04010222A (es) 2005-03-07
JP4433798B2 (ja) 2010-03-17
ATE374255T1 (de) 2007-10-15
EP1495142A4 (de) 2005-06-29

Similar Documents

Publication Publication Date Title
HUP0402271A2 (hu) Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek
BR0312121A (pt) xinalases, ácidos nucléicos codificando-as e métodos para preparar e empregá-las
ATE423221T1 (de) Verwendung von mass-matched nukleotide in der analyse von oligonukleotidmischungen sowie in der hoch-multiplexen nukleinsäuresequenzierung
ATE154029T1 (de) 7-deazapurin modifizierte oligonukleotide
DE60325016D1 (de) Oligonukleotide mit alternierenden segmenten und deren verwendungen
EP1225234A3 (de) Synthese von Nukleinsäuren
BRPI0315652B8 (pt) molécula de ácido nucleico isolada, vetor, polipeptídeo de fusão, e, multímero
CY1113096T1 (el) Αντισωματα της ip-10 και οι χρησεις αυτων
TR200002989T2 (tr) Heliomisin için gen kodu ve bunun kullanılması.
EE200300100A (et) Polüpeptiid, selle kodeerivat nukleotiidjärjestust sisaldav nukleiinhape, vektor ja peremeesrakk, meetod polüpeptiidi valmistamiseks ning farmatseutiline kompositsioon
WO2003000841A3 (en) Dye-labeled ribonucleotide triphosphates
HUP0303517A2 (hu) Hímfertilitást közvetítő nukleotidszekvenciák és alkalmazásuk
CY1109675T1 (el) Αντιμικροβιακα πολυπεπτιδια
BR9912455A (pt) ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
DE60316547D1 (de) Doping bei der walk-through-mutagenese
HUP9904414A2 (hu) A neuritin neurogén
ES2152313T3 (es) Gen grb-3-3, sus variantes y sus utilizaciones.
WO2001071007A3 (en) GENETIC POLYMORPHISM OF MxA PROTEIN AND USE THEREOF
WO1999014337A3 (en) New plant genes
ATE516365T1 (de) Nukleinsäureamplifikationsprimer zum nachweis von cytokeratinen und untersuchungsverfahren mit verwendung der primer
WO2002048401A3 (en) Nested oligonucleotides containing hairpin for nucleic acid amplification
SG146640A1 (en) Isolated photoprotein mtclytin, and use thereof
ATE510906T1 (de) Kv10.1, ein neuer potential-abhängiger kaliumkanal des menschlichen gehirns
ATE414905T1 (de) Diabetesmodell
WO2002031146A3 (en) Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1495142

Country of ref document: EP

Representative=s name: MAI DOERR BESIER PATENTANWAELTE, DE